| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers R > Headlines for Rosetta Genomics Ltd. > News item |
Rosetta Genomics cancels its $10 million at-the-market equity offering
Financing had been negotiated with agent Cantor Fitzgerald on March 22
By Devika Patel
Knoxville, Tenn., Oct. 14 – Rosetta Genomics Ltd. terminated its $10 million at-the-market equity offering with agent Cantor Fitzgerald & Co. on Oct. 13, according to an 8-K filed Tuesday with the Securities and Exchange Commission. The deal was announced as a $5.9 million offering on March 22 and increased on March 31.
Based in Rehovot, Israel, Rosetta Genomics develops and provides micro RNA-based molecular diagnostics.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.